For the year ending 2026-01-31, PHR has $663,790K in assets. $326,583K in debts. $73,830K in cash and cash equivalents.
| Balance Sheets | 2026-01-31 | |||
|---|---|---|---|---|
| Cash, cash equivalents, and restricted cash (including restricted cash of 1,691) | 73,830 | |||
| Settlement assets | 32,999 | |||
| Accounts receivable, net of allowance for doubtful accounts of 1,523 and 1,468 as of january31, 2026 and 2025, respectively | 97,453 | |||
| Cardholder receivables | 38,330 | |||
| Deferred purchase price receivables | 18,003 | |||
| Accrued interest and fees receivables | 840 | |||
| Deferred contract acquisition costs | 410 | |||
| Prepaid expenses and other current assets | 17,978 | |||
| Total current assets | 279,843 | |||
| Property and equipment, net of accumulated depreciation and amortization of 94,193 and 84,505 as of january31, 2026 and 2025, respectively | 20,332 | |||
| Capitalized internal-use software, net of accumulated amortization of 69,390 and 55,991 as of january31, 2026 and 2025, respectively | 54,270 | |||
| Operating lease right-of-use assets | 2,002 | |||
| Deferred contract acquisition costs | 338 | |||
| Intangible assets, net of accumulated amortization of 13,489 and 8,407 as of january31, 2026 and 2025, respectively | 79,761 | |||
| Goodwill | 170,064 | |||
| Deferred tax assets | 1,593 | |||
| Other assets | 2,442 | |||
| Long-term cardholder receivables | 47,723 | |||
| Long-term deferred purchase price receivables | 5,422 | |||
| Total assets | 663,790 | |||
| Settlement obligations | 32,999 | |||
| Current portion of debt and finance lease liabilities | 7,971 | |||
| Current portion of operating lease liabilities | 1,254 | |||
| Accounts payable | 11,477 | |||
| Accrued expenses | 41,257 | |||
| Due to healthcare providers | 38,056 | |||
| Deferred revenue | 49,522 | |||
| Other current liabilities | 705 | |||
| Total current liabilities | 183,241 | |||
| Long-term debt and finance lease liabilities | 92,117 | |||
| Operating lease liabilities, non-current | 1,107 | |||
| Long-term due to healthcare providers | 45,329 | |||
| Long-term deferred revenue | 244 | |||
| Long-term deferred tax liabilities | 4,498 | |||
| Other long-term liabilities | 47 | |||
| Total liabilities | 326,583 | |||
| Common stock, 0.01 par value500,000,000 shares authorized as of both january31, 2026 and 2025 62,020,186 and 60,083,444 shares issued as of january31, 2026 and 2025, respectively | 620 | |||
| Additional paid-in capital | 1,181,679 | |||
| Accumulated deficit | -799,190 | |||
| Accumulated other comprehensive loss | -382 | |||
| Treasury stock, at cost, 1,355,169 shares as of both january31, 2026 and 2025 | 45,520 | |||
| Total stockholders equity | 337,207 | |||
| Total liabilities and stockholders equity | 663,790 | |||
Phreesia, Inc. (PHR)
Phreesia, Inc. (PHR)